Stenotrophomonas Maltophilia
- PMID: 34283489
- Bookshelf ID: NBK572123
Stenotrophomonas Maltophilia
Excerpt
Stenotrophomonas maltophilia is a gram-negative bacillus, initially called Bacterium bookeri, when it was first identified in 1943 from a specimen of human pleural fluid. It was later classified as Pseudomonas maltophilia in 1961, then reassigned to the gammaproteobacteria class as Xanthomonas maltophilia in 1983, and eventually classified as a Stenotrophomonas in 199. The name has Greek roots meaning “The narrow feeder - that loves malt.” The whole-genome sequence of representative isolate K279a genome sequence was published in 2008.
S. maltophilia can be considered a “newly emerging pathogen of concern” that is being isolated more frequently. It is also recognized as one of the underestimated important multi-drug resistant organisms in hospitals by the World Health Organization (WHO). It was ranked as the ninth most important one per British microbiologists and one of the challenging pathogens in the infectious disease community and studies. It is widely known as an opportunistic organism associated with high morbidity and mortality rates among immunocompromised patients.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Palleroni NJ, Bradbury JF. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int J Syst Bacteriol. 1993 Jul;43(3):606-9. - PubMed
-
- Looney WJ. Role of Stenotrophomonas maltophilia in hospital-acquired infection. Br J Biomed Sci. 2005;62(3):145-54; quiz 1 p following 154. - PubMed
-
- Pinot C, Deredjian A, Nazaret S, Brothier E, Cournoyer B, Segonds C, Favre-Bonté S. Identification of Stenotrophomonas maltophilia strains isolated from environmental and clinical samples: a rapid and efficient procedure. J Appl Microbiol. 2011 Nov;111(5):1185-93. - PubMed
-
- Abbott IJ, Peleg AY. Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies. Semin Respir Crit Care Med. 2015 Feb;36(1):99-110. - PubMed
-
- Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Saunders D, Arrowsmith C, Carver T, Peters N, Adlem E, Kerhornou A, Lord A, Murphy L, Seeger K, Squares R, Rutter S, Quail MA, Rajandream MA, Harris D, Churcher C, Bentley SD, Parkhill J, Thomson NR, Avison MB. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 2008 Apr 17;9(4):R74. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources